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Abstract
Past studies have shown that melanoma cells have largely adapted to endoplasmic reticulum (ER) stress. In this study,
we report that melanoma cells under ER stress are more resistant to apoptosis induced by the microtubule-targeting
chemotherapeutic drugs, docetaxel and vincristine, and this is, at least in part, due to activation of the phosphoinositide
3-kinase (PI3K)/Akt pathway mediated by the X-box–binding protein 1 (XBP-1) axis of the unfolded protein response.
Treatment with the ER stress-inducer tunicamycin (TM) or thapsigargin before the addition of docetaxel or vincristine
reduced the levels of apoptosis induced by the drugs. This was associated with inhibition of mitochondrial release of
apoptogenic proteins and activation of Bax and Bak. Induction of ER stress resulted in the rapid activation of the PI3K/
Akt pathway that seemed to be important in antagonizing docetaxel and vincristine, in that inhibition of Akt blocked
the effect of pretreatment with TM on apoptosis induced by the drugs. Neither docetaxel nor vincristine triggered ER
stress in melanoma cells, but the basal activity of XBP-1 signaling seemed to play a role in the protection against
the drugs because small interfering RNA knockdown of XBP-1 enhanced docetaxel- and vincristine-induced apoptosis.
In addition, inhibition of XBP-1 decreased the constitutive levels of activation of Akt and blocked the activation of
Akt induced by TM. Taken together, these results identify activation of the PI3K/Akt pathway by XBP-1–mediated
signaling of the unfolded protein response as a resistance mechanism against docetaxel and vincristine in melanoma
cells under ER stress.
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Introduction
Melanoma continues to increase in incidence in many parts of the world,
but there is currently no curative treatment once the disease has spread
beyond the primary site because of the absence of effective systemic ther-
apies. This is believed to be largely due to the resistance of melanoma
cells to induction of apoptosis by available chemotherapeutic drugs
and biological reagents [1,2]. Inappropriate activation of survival sig-
naling pathways such as those mediated by mitogen-activated protein
kinase kinase (MEK)/extracellular-regulated kinase (ERK) and phos-
phoinositide 3-kinase (PI3K)/Akt, either as consequences of genetic
alterations or resulting from environmental stimulations, is known to
play a central role in the resistance of melanoma to apoptosis [1,2].
A number of cellular stress conditions, such as nutrient deprivation,
hypoxia, and alterations in glycosylation status, lead to the accumula-
tion of unfolded and/or misfolded proteins in the endoplasmic reticu-
lum (ER) lumen and cause so-called ER stress [3–5]. The ER responds
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GRP78, glucose-regulated protein 78; IRE1α, inositol-requiring transmembrane ki-
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to stress conditions by activating a range of signaling pathways that
couples the ER protein folding load with the ER protein folding
capacity and is termed the unfolded protein response (UPR) [3–5].
The UPR of mammalian cells is initiated by three ER transmembrane
proteins, namely, activating transcription factor 6 (ATF6), inositol-
requiring enzyme 1 (IRE1), and double-stranded RNA-activated pro-
tein kinase-like ER kinase (PERK), which act as proximal sensors of
ER stress. Under unstressed conditions, the luminal domains of these
sensors are occupied by the ER chaperon glucose-regulated protein
78 (GRP78) [3–5]. Upon ER stress, sequestration of GRP78 by un-
folded proteins activates these sensors by inducing phosphorylation
and homodimerization of IRE1 and PERK and relocalization of
ATF6 to the Golgi where it is cleaved by Sites 1 and 2 proteases leading
to its activation as a transcriptional factor [3–5].
There is increasing evidence that the UPR is activated in various
solid tumors, e.g., elevated expression of GRP78 has been reported in
a number of cancers [6,7]. Our previous studies have shown that
GRP78 is also expressed at higher levels in most melanoma cell lines
and that the levels of GRP78 expression on melanoma tissue sections
increase with melanoma progression [8–10]. Similarly, another effector
of UPR activation, the spliced X-box–binding protein 1 (XBP-1) mes-
senger RNA (mRNA), is frequently expressed inmelanoma cell lines and
freshmelanoma isolates [10]. Given the highlymalignant nature ofmela-
noma, it is conceivable that the rapid growth rate and perhaps inadequate
vascularization would create a microenvironment with hypoxia and glu-
cose deprivation, which in turn results in ER stress [8,11]. Recently, it
was shown that the UPR can be activated at early stages of melanoma
initiation by the ongogenic form of HRAS (HRASG12V) [12].
Although the UPR is fundamentally a cytoprotective response, exces-
sive or prolonged UPR can result in apoptosis by activation of many of
the same molecules that have important roles in other apoptotic cascades
[13–16]. Nevertheless, most humanmelanoma cell lines are not sensitive
to apoptosis induced by ER stress [8,10]. Multiple mechanisms, either
constitutively activated, or induced by the UPR, play roles in the protec-
tion of melanoma cells against ER stress–induced apoptosis. For ex-
ample, up-regulation of the antiapoptotic Bcl-2 family protein Mcl-1
is critical for neutralizing the BH3-only proteins PUMA and Noxa that
are also upregulated by ER stress in melanoma cells [17]. Moreover, ac-
tivation of the UPR is known to protect against apoptosis induced by
various chemotherapeutic drugs in many cancer types [6,7,11]. We have
found that up-regulation of GRP78 plays a role in antagonizing the
DNA-damaging drugs cisplatin and adriamycin in melanoma [10]. Ac-
tivation of X-box–binding protein 1 (XBP-1) has also been shown to in-
hibit apoptosis induced by a number of chemotherapeutic drugs [18].
In this study, we have examined the role of activation of the UPR in
regulating the sensitivity of melanoma cells to apoptosis induced by two
microtubule-targeting chemotherapeutic drugs, docetaxel and vincristine.
We show in this report that induction of ER stress leads to increased
resistance of melanoma cells to apoptosis induced by the drugs. This is,
at least in part, due to the activation of the PI3K/Akt pathway mediated
by the XBP-1 axis of theUPR.We demonstrate that neither docetaxel nor
vincristine triggers ER stress inmelanoma cells, but the basal activity of the
UPR plays a role in protection of melanoma cells against the drugs.
Materials and Methods
Cell Lines
Human melanoma cell lines Mel-RM, MM200, Mel-CV, ME4405,
Sk-Mel-28, andMel-FH have been described previously [19]. They were
cultured in Dulbecco’s modified Eagle’s medium containing 5% fetal calf
serum (Commonwealth Serum Laboratories, Melbourne, Australia).
Antibodies, Recombinant Proteins, and Other Reagents
Tunicamycin (TM) and thapsigargin (TG) were purchased from
Sigma Chemical Co. (Castle Hill, Australia). They were dissolved in
dimethyl sulfoxide and made up in stock solutions of 1 mM. Docetaxel
(Taxotere) was kindly provided by Aventis Pharma S.A. (Antony,
France) and was stored as a 100-mM solution in absolute ethanol at
−80°C and diluted with the medium before use. Vincristine was pro-
vided by Baxter Healthcare Pty., Ltd (Newcastle, Australia) that is in
0.9% sodium chloride solution at 1 mg/25 ml. The PI3K inhibitor,
2-(4-morpholinyl)-8-phenyl-4H -1-benzopyran-4-one (LY294002),
was purchased from Calbiochem (Kilsyth, Victoria, Australia). The
rabbit polyclonal antibodies against Smac, GRP78, XBP-1, IRE1α,
ATF6, and PERK were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). The mouse monoclonal antibody (mAb) against cyto-
chrome c was from Pharmingen (Bioclone, Marrickville, Australia). The
rabbit polyclonal anti-Bax against amino acids 1 through 20 was pur-
chased from Upstate Biotechnology (Lake Placid, NY). The mouse
mAb against Bak (Ab-1) was purchased from Calbiochem (La Jolla,
CA). Isotype control antibodies used were the ID4.5 (mouse immuno-
globulin G 2a [IgG2a]) mAb against Salmonella typhi supplied by
Dr. L. Ashman (Institute for Medical and Veterinary Science, Adelaide,
Australia), the 107.3 mouse IgG1 mAb purchased from PharMingen
(San Diego, CA), and rabbit IgG from Sigma Chemical Co.
Apoptosis
Quantitation of apoptotic cells by measurement of sub-G1 DNA
content using the propidium iodide method was carried out as described
elsewhere [19,20].
Flow Cytometry
Immunostaining on intact and permeabilized cells was carried
out as described previously [19,20]. Analysis was carried out using
a Becton Dickinson (Mountain View, CA) FACScan flow cytometer.
Mitochondrial Membrane Potential (ΔΨm)
Changes in ΔΨm were studied by staining the cells with the cationic
dye, JC-1, according to the manufacturer’s instructions (Molecular
Probes, Eugene, OR) as described previously [20].
Western Blot Analysis
Western blot analysis was carried out as described previously [10,17].
Labeled bands were detected by Immun-Star HRP Chemiluminescent
Kit, and images were captured and the intensity of the bands was quan-
titated with the Bio-Rad VersaDoc image system (Bio-Rad, Regents
Park, NSW, Australia).
Detection of XBP-1 mRNA Splicing
The method used for the detection of unspliced and spliced XBP1
mRNA was as described previously [11,21].
Small Interference RNA
Melanoma cells were seeded at 4 × 104 cells per well in 24-well
plates and allowed to reach approximately 50% confluence on the
day of transfection [10,17]. The small interference RNA (siRNA) con-
structs used were obtained as the siGENOME SMARTpool reagents
(Dharmacon, Lafayette, CO), the siGENOME SMARTpool GRP78
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(M-008198-0010), the siGENOME SMARTpool IRE1α (M-004951-
01-0010), the siGENOME SMARTpool ATF6 (M-009917-00-0010),
the siGENOME SMARTpool PERK (M-004883-01-0010), the
siGENOME SMARTpool Akt3 (M-003002-01-0010), and the
siGENOME SMARTpool XBP-1 (M-009552-02). The nontargeting
siRNA control, SiConTRolNon-targeting SiRNA pool (D-001206-
13-20), was also obtained from Dharmacon. Cells were transfected with
50 to 100 nM siRNA in Opti-MEM medium (Invitrogen, Carlsbad,
Figure 1. Induction of ER stress protects melanoma cells against apoptosis induced by docetaxel and vincristine. (A) Mel-RM and
MM200 cells were pretreated with TM (3 μM) for 24 hours before the addition of docetaxel (20 nM) for a further 48 hours (left panel)
or were cotreated with TM (3 μM) and docetaxel (20 nM) for 48 hours (right panel). Apoptosis was measured by the propidium iodide
method using flow cytometry. (B) Mel-RM and MM200 cells were pretreated with TM (3 μM) for indicated periods before the addition of
docetaxel (20 nM) for another 48 hours. Apoptosis was measured by the propidium iodide method using flow cytometry. The data
shown (y-axis) are percentages of inhibition of apoptosis. (C) Mel-RM and MM200 cells were pretreated with TM (3 μM) for 6 hours
before the addition of docetaxel (20 nM) for a further 36 hours. Whole cell lysates were subjected to Western blot analysis. (D) Mel-RM
and MM200 cells were pretreated with TM (3 μM) for 6 hours before the addition of vincristine (50 ng/ml) for another 48 hours (left panel)
or were cotreated with TM (3 μM) and vincristine (50 ng/ml) for 48 hours (right panel). Apoptosis was measured by the propidium iodide
method using flow cytometry. (E) Melanoma cells were pretreated with TM (3 μM) for 24 hours before the addition of vincristine (50 ng/ml)
for a further 48 hours. Apoptosis was measured by the propidium iodide method using flow cytometry. (F) Melanoma cells were pretreated
with TG (1 μM) for 24 hours before the addition of docetaxel (20 nM) or vincristine (50 ng/ml) for a further 48 hours. Apoptosis was mea-
sured by the propidium iodide method using flow cytometry. The data shown are either the mean ± SE (A, B, D, E, and F) or are a rep-
resentative (C) of three individual experiments.
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CA) with 5% fetal calf serum using Lipofectamine reagent (Invitrogen)
according to the manufacturer’s transfection protocol. Twenty-four hours
after transfection, the cells were switched into a medium containing 5%
fetal calf serum and were treated as designed.
Results
Induction of ER Stress Protects Melanoma Cells from
Docetaxel- and Vincristine-Induced Apoptosis
Human melanoma cells have largely adapted to ER stress [8,17].
To study the potential effect of this adaptation on the sensitivity of
melanoma cells to microtubule-targeting chemotherapeutic drugs, we
treated Mel-RM and MM200 cells with TM, a naturally occurring
antibiotic that induces ER stress by inhibiting glycosylation [22], for
24 hours before the addition of docetaxel for a further 48 hours. As
reported before [16,17,21], TM alone induced only moderate levels of
apoptosis (<10% apoptotic cells), whereas docetaxel induced apoptotic
cell death in approximately 45% and 20% of Mel-RM and MM200
cells, respectively (Figure 1A). Pretreatment with TM for 24 hours
markedly reduced the levels of apoptosis induced by docetaxel (P <
.01, 2-tailed Student’s t test), but coadministration of TM and docetaxel
resulted in similar levels of apoptosis to those induced by docetaxel
alone (Figure 1A). These results indicate that the inhibitory mecha-
nism(s) activated by TM needs to be present before exposing melanoma
cells to docetaxel.
To study the time frame required for the activation of the TM-
mediated protective mechanism(s), we reduced the periods of treatment
with TM before the addition of docetaxel. As shown in Figure 1B,
although pretreatment with TM for as short as 3 hours reduced the
levels of docetaxel-induced apoptosis by around 30% in both Mel-RM
and MM200 cells, the degrees of inhibition seemed to be progressively
attenuated with shorter pretreatment periods. Figure 1C shows that pre-
treatment with TM partially inhibited docetaxel-induced activation of
caspase-3 and cleavage of its substrate poly (ADP-ribose) polymerase.
As shown in Figure 1D, pretreatment with TM also significantly
blocked apoptosis induced by another microtubule-targeting drug,
namely, vincristine, in Mel-RM andMM200 cells (P < .01, 2-tailed Stu-
dent’s t test). In contrast, coadministration of TM and vincristine did not
have any notable effect on apoptosis induced by vincristine (Figure 1D).
Protection of melanoma cells from docetaxel- and vincristine-induced
apoptosis by preexposure to TMwas confirmed in four other melanoma
cell lines (Figure 1E). Similarly, pretreatment with TG that induces ER
stress by inhibiting ERCa2+ ATPases [23] also protected against apopto-
sis induced by the drugs in a panel of melanoma cell lines (Figure 1F ).
Figure 1. (continued).
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Induction of ER Stress Inhibits Mitochondrial Apoptotic
Events Induced by Docetaxel and Vincristine
To elucidate the stage at which apoptotic signaling induced by
docetaxel and vincristine is inhibited by pretreatment with TM, we
examined the effect of pretreatment with TM on changes in ΔΨm
induced by the drugs. As shown in Figure 2A, both docetaxel and
vincristine induced reduction in ΔΨm as reported before [24,25], but
the reduction was attenuated by pretreatment with TM. Figure 2B
shows that pretreatment with TM reduced the cytosolic levels of cyto-
chrome c and Smac/DIABLO in comparison with those in cells treated
with docetaxel alone, indicating inhibition of mitochondrial release of
these apoptogenic proteins. Similarly, pretreatment with TM blocked
the activation of Bax and Bak induced by the docetaxel as detected with
the antibodies that specifically recognize the activated forms of Bax and
Bak, respectively (Figure 2C ) [20,26].
Protection of Melanoma Cells against Docetaxel- and
Vincristine-Induced Apoptosis by Pretreatment with
TM Is Associated with Activation of Akt
Our previous studies have shown that induction of apoptosis of
melanoma cells by docetaxel and vincristine is inhibited by activation
of the MEK/ERK pathway [24,25]. However, treatment with TM
does not induce further activation of MEK/ERK that is constitutively
activated in melanoma cells [21]. This argues against a major role of
this survival pathway in the protection induced by pretreatment with
TM. To elucidate the protective mechanism(s) activated by TM, we
monitored the activation status of the PI3K/Akt survival pathway in
Mel-RM and MM200 cells before and after treatment with TM.
Figure 3A shows that exposure to TM induced increases in activation
(phosphorylation) of Akt that were detectable as soon as 1 to 3 hours.
The elevated levels of activation of Akt sustained for up to 16 to
24 hours after exposure to TM (Figure 3A). Activation of Akt by TM
was observed in four other melanoma cell lines (Figure 3B).
To study if the activation of Akt by ER stress plays a role in the pro-
tection of melanoma cells against docetaxel and vincristine, we treated
Mel-RM and MM200 cells with the PI3K inhibitor LY294002 before
the addition of TM followed by docetaxel and vincristine. Whereas
LY294002 inhibited TM-induced activation of Akt (Figure 3C ), it re-
versed the resistance of melanoma cells to apoptosis induced by TM and
enhanced the apoptosis induced by docetaxel or vincristine alone
(Figure 3D). In the presence of LY294002, protection against docetaxel-
and vincristine-induced apoptosis and reduction in ΔΨm by pretreat-
ment with TM were abrogated (Figure 3, D and E).
Figure 2. Pretreatment with TM inhibits mitochondrial apoptotic events induced by docetaxel and vincristine. (A) Mel-RM and MM200
cells were pretreated with TM (3 μM) for 6 hours before the addition of docetaxel (20 nM) or vincristine (50 ng/ml) for a further 36 hours.
Cells were subjected to measurement of ΔΨm by JC-1 staining in flow cytometry. The number in each left-bottom quadrant represents
the percentage of cells with reduction in ΔΨm. (B) Mel-RM and MM200 cells with or without pretreatment with TM (3 μM) for 6 hours
were treated with docetaxel (20 nM) for a further 36 hours. Cytosolic fractions were isolated and were subjected to Western blot
analysis of cytochrome c and Smac/DIABLO expression. (C) Mel-RM and MM200 cells with or without pretreatment with TM (3 μM)
for 6 hours were treated with docetaxel (20 nM) for a further 36 hours. Cells were permeabilized and subjected to measurement of
activation of Bax and Bak by flow cytometry using antibodies that specifically recognize activated Bax and Bak, respectively. The
filled histograms were generated from cells treated with TM alone, the thin open histograms were generated from cells treated with
docetaxel alone, and the thick open histograms were generated from cells pretreated with TM followed by the addition of docetaxel. The
data shown are representative of three individual experiments.
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To confirm that the effect of LY294002 was due to the inhibition of
the activation of Akt, we transfected an siRNA pool for Akt3, the major
isoform of Akt in melanoma [27], into Mel-RM and MM200 cells.
siRNA knockdown of Akt3 markedly reduced its expression levels and
activation of Akt induced by TM (Figure 4A). Similar to LY294002,
knockdown of Akt3 by siRNA inhibited the effect of pretreatment with
TM on apoptosis induced by docetaxel and vincristine (Figure 4B).
ER Stress–Induced Activation of Akt Is Associated with the
IRE1α and ATF6 Pathways of the UPR
We investigated the signaling pathways of the UPR responsible for the
activation of the PI3K/Akt pathway in melanoma cells under ER stress
by transfecting siRNA pools for IRE1α, ATF6, and PERK intoMel-RM
and MM200 cells, respectively. Figure 5A shows that siRNA knock-
down of each of theseUPR transducers inhibited its expression by at least
Figure 3. Activation of the PI3K/Akt pathway contributes to protection of melanoma cells against docetaxel and vincristine by pretreat-
ment with TM. (A) Whole cell lysates from Mel-RM and MM200 cells treated with TM (3 μM) for indicated periods were subjected to
Western blot analysis. The arrowhead points to nonspecific bands. (B) Whole cell lysates from melanoma cells treated with TM (3 μM)
for 6 hours were subjected to Western blot analysis. The arrowhead points to nonspecific bands. (C) Mel-RM and MM200 cells were
treated with LY294002 (20 μM) for 1 hour before the addition of TM (3 μM) for another 6 hours. Whole cell lysates were subjected to
Western blot analysis. (D) Mel-RM (upper panel) and MM200 (lower panel) cells were treated with LY294002 (20 μM) for 1 hour before
the addition of TM (3 μM) for 6 hours followed by docetaxel (20 nM) or vincristine (50 ng/ml) for a further 48 hours. Apoptosis was
measured by the propidium iodide method using flow cytometry. (E) Mel-RM and MM200 cells were treated with LY294002 (20 μM)
for 1 hour before the addition of TM (3 μM) for 6 hours followed by docetaxel (20 nM) or vincristine (50 ng/ml) for a further 48 hours.
Mitochondrial membrane potential was measured using JC-1 staining by flow cytometry. The data shown are either representative (A, B,
and C) or are the mean ± SE (D and E) of three individual experiments.
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70% and had no notable effects on the expression of the others. As
shown in Figure 5B, the levels of activation of Akt induced by TM were
reduced in cells transfected with the siRNA for IRE1α and, to a lesser
extent, in cells transfected with the siRNA for ATF6. Notably, the basal
levels of activation of Akt were also decreased in cells with IRE1α or
ATF6 knocked down. Inhibition of PERK by siRNA did not have any
notable effect on activation of Akt before and after treatment with TM.
We studied if the basal activity of each arm of the UPR pathways
plays a role in regulating sensitivity of melanoma cells to docetaxel
and vincristine. As shown in Figure 5C , siRNA inhibition of IRE1α
or ATF6 enhanced apoptosis induced by docetaxel and vincristine and
reversed resistance to TM-induced apoptosis in Mel-RM and MM200
cells. As expected, induction of apoptosis by docetaxel or vincristine in
melanoma cells pretreated with TM was also enhanced by siRNA
knockdown of IRE1α or ATF6 (Figure 5C ). Inhibition of PERK
by siRNA did not result in any notable effect on apoptosis induced
by TM, docetaxel, or vincristine alone and in the protection against
docetaxel or vincristine by pretreatment with TM (data not shown).
Figure 4. siRNA knockdown of Akt3-enhanced apoptosis induction abolishes protection against apoptosis induced by docetaxel and
vincristine by pretreatment with TM. (A) Upper panel: Mel-RM and MM200 cells were transfected with the control or Akt3 siRNA. Twenty-
four hours later, whole cell lysates were subjected to Western blot analysis. Lower panel: Mel-RM and MM200 cells were transfected with
the control or Akt3 siRNA. Twenty-four hours later, cells were treated with TM (3 μM) for 6 hours. Whole cell lysates were subjected to
Western blot analysis. (B) Mel-RM (left panel) and MM200 (right panel) cells were transfected with the control or Akt3 siRNA. Twenty-four
hours later, cells were treated with TM (3 μM) for 6 hours followed by the addition of docetaxel (20 nM) or vincristine (50 ng/ml) for a further
48 hours. Apoptosis was measured by the propidium iodide method using flow cytometry. The data shown are either representative (A) or
are the mean ± SE (B) of three individual experiments.
Figure 5. siRNA knockdown of IRE1α or ATF6 blocks activation of Akt by TM. (A) Mel-RM and MM200 cells were transfected with the
control, IRE1α, ATF6, or PERK siRNA. Twenty-four hours later, whole cell lysates were subjected to Western blot analysis. (B) Mel-RM
and MM200 cells were transfected with the control, IRE1α, ATF6, or PERK siRNA as shown in panel A. Twenty-four hours later, cells
were treated with TM (3 μM) for 6 hours. Whole cell lysates were subjected to Western blot analysis. (C) Mel-RM (upper panel) and
MM200 (lower panel) cells were transfected with the control, IRE1α, or ATF6 siRNA. Twenty-four hours later, cells were treated with TM
(3 μM) for 6 hours followed by the addition of docetaxel (20 nM) or vincristine (50 ng/ml) for a further 48 hours. Apoptosis was measured
by the propidium iodide method using flow cytometry. The data shown are either representative (A and B) or are the mean ± SE (C) of
three individual experiments.
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ER Stress–Induced Activation of Akt Is Mediated by XBP-1
The IRE1α and ATF6 signaling pathways of the UPR converge on
the UPR effector XBP-1, as XBP-1 is transcriptionally regulated by
ATF6, but its activation is mediated by IRE1α [3–5]. We therefore
envisage that XBP-1 plays a role in the activation of Akt induced by
the UPR. To test this, we transfected an siRNA pool for XBP-1 into
Mel-RM and MM200 cells. Figure 6A shows that the XBP-1 siRNA
inhibited the XBP-1 levels by more than 70% in both cell lines. Ac-
tivation of XBP-1, as indicated with XBP-1 mRNA splicing, by TM
was also markedly reduced in cells transfected with the XBP-1 siRNA
(Figure 6A). As shown in Figure 6B, inhibition of XBP-1 by siRNA
reduced the basal levels of activation of Akt and blocked TM-induced
activation of Akt in both cell lines, indicating that XBP-1 plays a role in
the activation of Akt in melanoma cells when submitted to ER stress.
Figure 6C shows that siRNA knockdown of XBP-1 sensitized mela-
noma cells to apoptosis induced by TM, docetaxel, and vincristine.
Protection of melanoma cells against docetaxel and vincristine by pre-
treatment with TM was abolished in melanoma cells with XBP-1
knocked down by siRNA (Figure 6C).
We also examined if GRP78, which is known to protect against
various chemotherapeutic drugs in melanoma cells [6,7,11], is in-
volved in regulating the sensitivity of melanoma cells to docetaxel
and vincristine. Figure 6D shows that transfection of an siRNA pool
for GRP78 markedly inhibited its expression, but had no effect on
the expression of GRP94, in Mel-RM and MM200 cells. siRNA
knockdown of GRP78 did not have any notable effect on the levels
of apoptosis induced by docetaxel or vincristine (Figure 6D).
Docetaxel and Vincristine Do Not Trigger ER Stress in
Melanoma Cells
A number of clinically available chemotherapeutic drugs and those
in development for clinical use can induce ER stress in melanoma
[16,28]. To test if docetaxel and vincristine can similarly induce
ER stress and activate the UPR in melanoma cells, we monitored
the levels of the GRP78 protein and the spliced (active) XBP-1
mRNA in melanoma cells treated with docetaxel or vincristine. Cells
treated with TM were included as controls. Whereas TM induced
marked up-regulation of the GRP78 protein and spliced XBP-1
mRNA in Mel-RM and MM200 cells, neither docetaxel nor vincris-
tine caused notable changes in the expression of the indicators of ac-
tivation of the UPR (Figure 7, A and B). The inability of the drugs in
the induction of GRP78 was also confirmed in four other melanoma
cell lines (Figure 7C ).
Discussion
Resistance of melanoma cells to chemotherapeutics is a major ob-
stacle to successful treatment of melanoma once it has spread beyond
locoregional sites [1,2,29]. In the present study, we show that in-
duction of ER stress renders melanoma cells even more resistant to
two microtubule-targeting chemotherapeutic drugs, docetaxel and
vincristine. Our results suggest that adaptation of melanoma cells
to ER stress may be an important mechanism of resistance of mela-
noma cells to the drugs.
In the search for the protective mechanism(s) against docetaxel and
vincristine resulting from preloaded ER stress, we found that expo-
sure to TM induced activation of the PI3K/Akt pathway. Kinetically,
TM-induced activation of Akt occurred as early as 1 to 3 hours, and
the elevated activation levels sustained till 16 to 24 hours. This con-
formed to the time frame needed by TM to activate the protective
mechanism(s) against the drugs. Moreover, inhibition of Akt activation
by either the PI3K inhibitor LY294002 or the siRNA knockdown of
Akt3 reversed the protection against vincristine- or docetaxel-induced
apoptosis by pretreatment with TM. When LY294002 was imple-
mented after initiating the activation of Akt, its effect on TM-mediated
protection against the drugs was attenuated. This further confirms the
importance of preexisting Akt activity in antagonizing apoptotic sig-
naling induced by docetaxel and vincristine, neither of which induces
activation of the PI3K/Akt pathway in melanoma cells [24,25]. Taken
together, these results identify activation of Akt as an important pro-
tective mechanism against docetaxel and vincristine in melanoma cells
undergoing ER stress.
ER stress–induced activation of Akt has been speculated to be due
to the increases in intracellular calcium [30], as disruption of calcium
homeostasis is one of the characteristics of ER stress and calcium
plays critical roles in the activation of PI3K [1–3,31,32]. However,
activation of Akt by glucosamine through induction of ER stress was
shown not to be associated with increased release of calcium into the
cytosol [33]. We found that TM-induced activation of Akt was par-
tially inhibited by siRNA knockdown of IRE1α or ATF6, indicating
that these pathways of the UPR are involved in the activation of Akt in
melanoma cells under ER stress. Because XBP-1 is transcriptionally
regulated by ATF6 and is activated by IRE1α [3–5], it seemed that
XBP-1 may play a part in the activation of Akt mediated by the
UPR. In this study, inhibition of XBP-1 by siRNA reduced the levels
of constitutively activated Akt and blocked TM-induced Akt activa-
tion, verifying a role of XBP-1 in UPR-mediated activation of Akt.
It was recently shown that ER stress activated Akt in a zebrafish em-
bryonic cell line through XBP-1–mediated up-regulation of insulin
growth factor-1 (IGF-1) [34]. However, IGF-1/IGF-1 receptor signaling
in melanoma cells originates mainly from exogenous IGF-1 because
melanoma cells express no, or minimal, IGF-1 [35,36]. Nevertheless,
it is possible that XBP-1 will activate a factor or factors similar to
IGF-1 that in turn causes activation of the PI3K/Akt pathway in mela-
noma cells under ER stress. IRE1α is known to be responsible for ER
stress–induced activation of Jun N-terminal kinase and p38 by forming
complexes with TNF receptor–associated factor 2 and apoptosis signal–
regulating kinase 1 [37,38]. Whether this is also involved in the activa-
tion of Akt by TM in melanoma cells remains to be studied.
Activation of Akt is known to protect against apoptosis induced
by a number of stimuli [39–41]. Several proapoptotic proteins, such
as the BH3-only protein Bad, forkhead transcription factors, and
caspase-9, have been identified as direct targets of Akt [39,40]. In
addition, induction of the inhibitor of apoptosis protein (IAP) family
members XIAP and cIAP2 by Akt has also been reported to be
responsible for the inhibition of ER stress–induced apoptosis down-
stream of mitochondria [30]. However, inhibition of docetaxel- and
vincristine-induced apoptotic signaling in melanoma cells submitted
to ER stress seemed to take place upstream of mitochondrial apop-
totic events, suggesting that activation of Akt by TM may act on
one or more Bcl-2 family proteins to protect melanoma cells from
docetaxel- and vincristine-induced apoptosis.
A Bcl-2 family protein that may play a role in antagonizing
docetaxel and vincristine in melanoma cells submitted to ER stress
is Mcl-1, which can be regulated by Akt [42–44]. Mcl-1 is upregulated
by ER stress and plays a critical role in the protection of melanoma
cells from ER stress–induced apoptosis by neutralizing the BH3-only
proteins PUMA and Noxa [17]. The latter are also upregulated by ER
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Figure 6. XBP-1 mediates the activation of Akt induced by TM in melanoma cells. (A) Left panel: Mel-RM and MM200 cells were trans-
fected with the control or XBP-1 siRNA. Twenty-four hours later, cells were treated with TM for 16 hours. Whole cell lysates were sub-
jected to Western blot analysis. Right panel: Mel-RM and MM200 cells were transfected with the control or XBP-1 siRNA. Twenty-four
hours later, cells were treated with TM for 16 hours. Reverse transcription–polymerase chain reaction products of XBP1 mRNA were
digested with Apa-LI for 90 minutes followed by electrophoresis. (B) Mel-RM and MM200 cells were transfected with the control or
GRP78 siRNA. Twenty-four hours later, cells were treated with TM for another 6 hours. Whole cell lysates were subjected to Western
blot analysis. (C) Mel-RM and MM200 cells were transfected with the control or GRP78 siRNA. Twenty-four hours later, cells were
treated with TM for another 6 hours, followed by the addition of docetaxel (20 nM) or vincristine (50 ng/ml) for a further 48 hours.
Apoptosis was measured by the propidium iodide method using flow cytometry. (D) Upper panel: Mel-RM and MM200 cells were
transfected with the control or GRP78 siRNA. Twenty-four hours later, whole cell lysates were subjected to Western blot analysis of
GRP78 and GRP94. Lower panel: Mel-RM and MM200 cells were transfected with the control or GRP78 siRNA. Twenty-four hours
later, cells were treated with docetaxel (20 nM) or vincristine (50 ng/ml) for a further 48 hours. Apoptosis was measured by the
propidium iodide method using flow cytometry. The data shown are either representative (A, B, and D) or are the mean ± SE of three
individual experiments.
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stress [17]. However, neither PUMA nor Noxa plays a part in apop-
tosis induced by docetaxel and vincristine [24,25]. Nevertheless, Mcl-1
can also bind, albeit loosely, to another BH3-only protein Bad, which
is known to be involved in docetaxel-induced apoptosis of melanoma
cells [45].
A number of clinically available chemotherapeutic drugs and those in
development for clinical use can induce ER stress in various types of
cancer cells [16,28,46]. We have shown previously that the DNA-
damaging drugs cisplatin and adriamycin induce ER stress in melanoma
cell lines and that induction of GRP78 by the UPR plays an important
role in antagonizing these drugs [16]. Unlike cisplatin and adriamycin,
docetaxel and vincristine did not cause ER stress in the melanoma
cells. In this study, the sensitivity of melanoma cells to docetaxel- and
vincristine-induced apoptosis could not be enhanced by the inhibition
of GRP78. These results are in contrast to a recent report in which
another microtubule-targeting drug, namely, paclitaxel, was shown to
induce apoptosis of human lymphoma cells by triggering ER stress
[47]. Melanoma cells are biologically different from other cell types in
many aspects [2,8]. The difference in response to microtubule-targeting
drugs between the present study and others may therefore be due to
inherent characteristics of different cell types.
An important finding of this study is that the constitutive activa-
tion of the UPR is involved in the resistance of melanoma cells to
apoptosis induced by docetaxel and vincristine. Significantly, inhibi-
tion of IRE1α and ATF6 reduced the constitutive levels of Akt ac-
tivation in melanoma cells, suggesting that activation of the UPR by
chronic ER stress contributes to the constitutive activation of the
PI3K/Akt pathway. The observation that inhibition of Akt partially
reversed the resistance of melanoma cells to TM-induced apoptosis
indicates that activation of Akt in turn plays a role in the adaptation
of melanoma cells to ER stress, as does the MEK/ERK pathway [21].
In summary, we demonstrate in this report that induction of ER
stress protects melanoma cells against the microtubule-targeting che-
motherapeutic drugs docetaxel and vincristine. This is mediated, at
least in part, by the activation of PI3K/Akt through the XBP-1 axis
of the UPR. In addition, we show that XBP-1 contributes to the
basal levels of Akt activation in melanoma cells, which in turn plays
a role in the resistance of melanoma cells to apoptosis induced by ER
stress and by docetaxel and vincristine. The results from this study
suggest that targeting XBP-1 may be useful in improving the thera-
peutic effects of microtubule-targeting drugs in melanoma. More-
over, therapeutics that can induce ER stress in melanoma cells
such as cisplatin and fenretinide may cause an antagonistic effect
when combined with docetaxel or vincristine [16,28].
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